08 Feb 2024 Immune and Coagulation Dysregulation in Long COVID
08 Feb 2024 Beyond Dark Chocolate: Flavanol-Rich Foods May Reduce Risk for Essential Hypertension, Blood Clots
15 Nov 2023 In Memoriam: Robert Jennejahn (1951–2023)
10 Feb 2023 Has your practice seen an increase in blood clots since the COVID vaccines became available?
10 Feb 2023 Janssen’s Xarelto studied for secondary prevention of VTE in cancer patients
10 Feb 2023 Stryker’s Target Tetra detachable coil for treating small aneurysms cleared by FDA
10 Feb 2023 Corindus rebranded as Siemens Healthineers Endovascular Robotics
12 Dec 2022 Cook Medical Appoints John A. Kaufman as Chief Medical Officer

AVINGER RECEIVES FDA CLEARANCE FOR PANTHERIS DEVICE; SHARES AHEAD 47% PREMARKET

16 Jul 2018

0 138

Avinger has received 510(k) clearance from the FDA for its next generation Pantheris Lumivascular atherectomy system, the first-ever image-guided atherectomy device for the treatment of peripheral artery disease (P.A.D.).

Lumivascular is the only technology that combines real-time intravascular imaging with highly effective catheters for the treatment of P.A.D.

The Company intends to launch two versions of this product (standard and extended length nosecone) into initial sites in the United States immediately, and plans to incorporate the new design into the INSIGHT IDE clinical trial currently in progress.

Shares are up 47 percent premarket. VTN

Tags:Avinger FDA Lumivascular P.A.D.

AVINGER RECEIVES FDA CLEARANCE FOR PANTHERIS DEVICE; SHARES AHEAD 47% PREMARKET

MED-AESTHETIC SOLUTIONS INC., DEVELOPER OF SALT FACIAL, PARTNERS WITH AESTHETIC MANAGEMENT PARTNERS

STUDY SHOWS RESULTS CHANGING WHITE FAT INTO BROWN FAT FOR EASIER WEIGHT LOSS

Camden Lawless

FDA REMOVES THE RED TAPE ON TEST DEVELOPERS MARCH 18

FDA OKs HYPERFINE’s BEDSIDE MRI

VICI VENOUS STENT: FDA OKs VICI Venous Stent to treat Iliofemoral obstructive disease

AVINGER GETS FDA OK FOR PANTHERIS SV SMALL VESSEL ATHERECTOMY DEVICE

AVINGER RECEIVES FDA CLEARANCE FOR PANTHERIS DEVICE; SHARES AHEAD 47% PREMARKET

MED-AESTHETIC SOLUTIONS INC., DEVELOPER OF SALT FACIAL, PARTNERS WITH AESTHETIC MANAGEMENT PARTNERS

STUDY SHOWS RESULTS CHANGING WHITE FAT INTO BROWN FAT FOR EASIER WEIGHT LOSS

Camden Lawless

You Might Also Like

FDA REMOVES THE RED TAPE ON TEST DEVELOPERS MARCH 18

FDA OKs HYPERFINE’s BEDSIDE MRI

VICI VENOUS STENT: FDA OKs VICI Venous Stent to treat Iliofemoral obstructive disease

AVINGER GETS FDA OK FOR PANTHERIS SV SMALL VESSEL ATHERECTOMY DEVICE

AVINGER RECEIVES FDA CLEARANCE FOR PANTHERIS DEVICE; SHARES AHEAD 47% PREMARKET